Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) FCF Margin (2019 - 2025)

Pulmonx has reported FCF Margin over the past 7 years, most recently at 37.81% for Q3 2025.

  • Quarterly FCF Margin rose 324.0% to 37.81% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 33.74% through Sep 2025, up 988.0% year-over-year, with the annual reading at 37.9% for FY2024, 1701.0% up from the prior year.
  • FCF Margin was 37.81% for Q3 2025 at Pulmonx, down from 15.4% in the prior quarter.
  • Over five years, FCF Margin peaked at 15.4% in Q2 2025 and troughed at 144.55% in Q1 2022.
  • The 5-year median for FCF Margin is 59.9% (2025), against an average of 64.7%.
  • Year-over-year, FCF Margin skyrocketed 10273bps in 2021 and then tumbled -3700bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 86.43% in 2021, then surged by 32bps to 58.92% in 2022, then grew by 26bps to 43.84% in 2023, then skyrocketed by 46bps to 23.64% in 2024, then tumbled by -60bps to 37.81% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's FCF Margin are 37.81% (Q3 2025), 15.4% (Q2 2025), and 59.9% (Q1 2025).